Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ·Healthcare·Biotechnology
$3.40
-0.58%
Mkt Cap $53.91M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$13.25
Range $10.00 – $17.00
Implied Upside
+289.7%
Consensus $13.25 vs current $3.40
NASDAQ·Healthcare·Biotechnology
$3.40
-0.58%
Mkt Cap $53.91M
No recent rating data.
Price Target (4 analysts)
$13.25
Range $10.00 – $17.00
+289.7%
Consensus $13.25 vs current $3.40